Celcuity Inc. (CELC) Key Metrics

NASDAQ: CELCValuation, returns, debt and efficiency ratios over 10 years.

CELC valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$2.77B
Enterprise value
$3.91B
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
—
Price / book
78.9
10-yr median 5.1
EV / EBITDA
—
Dividend yield
—
Beta
0.11

CELC key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

CELC valuation Price multiples at each fiscal year-end price.

Price / book+1,066.8%
52.1
2025 · hover or tap a bar for each year
2018: 9.62019: 5.6 (−41.2%)2020: 8.0 (+42.5%)2021: 2.6 (−68.0%)2022: 1.6 (−37.1%)2023: 2.5 (+52.9%)2024: 4.5 (+80.9%)2025: 52.1 (+1,066.8%)
20162025
Free cash flow yield+13.3 pts
−2.9%
2025 · hover or tap a bar for each year
2018: −2.8%2019: −5.9% (−3.1 pts)2020: −7.7% (−1.8 pts)2021: −11.6% (−3.9 pts)2022: −16.7% (−5.2 pts)2023: −15.6% (+1.1 pts)2024: −16.2% (−0.6 pts)2025: −2.9% (+13.3 pts)
20162025

CELC valuation history

Fiscal year-endToday10-year median

CELC returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

CELC debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

CELC cash returned to shareholders

DividendsBuybacksFree cash flow

CELC price vs earnings per share

Share price at year-endEPS (right axis)

CELC key metrics

2016–2025
Celcuity Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$5.24B$516.4M$345.0M$216.0M$176.5M$94.0M$108.8M$242.9M——
Enterprise value$4.99B$379.2M$201.9M$82.7M$107.1M$82.6M$90.3M$218.0M——
Price / book52.14.52.51.62.68.05.69.6——
Earnings yield−3.4%−21.6%−18.5%−18.7%−16.8%−10.1%−6.8%−3.1%——
Free cash flow yield−2.9%−16.2%−15.6%−16.7%−11.6%−7.7%−5.9%−2.8%——
Shareholder yield (dividends + buybacks)———0.0%0.0%0.0%0.0%0.0%——
Share price at fiscal year-end$99.74$13.09$14.57$14.01$13.19$9.16$10.64$23.99$18.95—
Per share
Revenue per share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00——
Earnings per share−$3.37−$2.83−$2.69−$2.62−$2.21−$0.92−$0.72−$0.74——
Operating cash flow per share−$2.92−$2.12−$2.27−$2.34−$1.52−$0.70−$0.59−$0.60——
Free cash flow per share−$2.92−$2.12−$2.28−$2.35−$1.52−$0.70−$0.62−$0.66——
Cash per share$8.40$5.96$7.63$10.93$6.30$1.14$1.83$2.46——
Book value per share$1.91$2.93$5.90$8.68$5.13$1.14$1.89$2.50——
Tangible book value per share$1.91$2.93$5.90$8.68$5.13$1.14$1.89$2.50——
Capex per share$0.00$0.01$0.00$0.01$0.01$0.01$0.04$0.06——
Debt per share$3.72$2.48$1.58$2.29$1.11$0.03$0.03$0.00——
Shares outstanding52.5M39.4M23.7M15.4M13.4M10.3M10.2M10.1M——
Change in shares outstanding+33.2%+66.6%+53.6%+15.2%+30.3%+0.4%+1.0%———
Returns & profitability
Return on equity (ROE)−163.8%−87.5%−46.6%−39.9%−73.6%−61.1%−33.0%−26.4%−33.8%−62.3%
Return on invested capital (ROIC)——————−967.7%−163.4%−135.3%—
Return on assets (ROA)−49.8%−51.2%−34.8%−30.9%−59.9%−57.0%−31.8%−25.8%−32.9%−58.3%
Return on tangible assets−37.9%−45.6%−33.4%−23.0%−34.5%−73.1%−36.3%−28.7%−19.6%−54.7%
Financial health
Total debt$195.4M$98.0M$37.4M$35.2M$14.9M$262,488$256,137$25,610$0—
Cash & short-term investments$441.5M$235.1M$180.6M$168.6M$84.3M$11.7M$18.8M$24.9M$24.2M$5.9M
Net debt−$246.1M−$137.2M−$143.1M−$133.3M−$69.4M−$11.4M−$18.5M−$24.9M−$24.2M−$5.9M
Debt / equity1.940.850.270.260.220.020.010.000.00—
Debt / assets0.420.400.200.200.170.020.010.000.00—
Current ratio10.557.7113.4325.4534.0610.2621.1238.0742.3613.27
Quick ratio10.557.9813.4325.4834.1810.4321.3338.0742.3613.27
Interest coverage-10.0-11.0-12.4-18.7-22.5———-13.2—
Working capital$421.5M$212.8M$176.4M$168.3M$82.8M$11.0M$18.3M$24.6M$23.9M$5.5M
Invested capital−$145.6M−$21.5M−$3.4M$422,230−$690,053$304,838$796,697$477,705$7.2M−$244,730
Tangible asset value$100.6M$115.6M$139.8M$133.8M$68.7M$11.7M$19.3M$25.3M$31.4M$5.6M
Net current asset value$99.7M$115.1M$139.1M$133.2M$68.2M$10.9M$18.3M$24.5M$23.9M$5.5M
Graham net-net per share$1.44$2.60$5.48$8.22$5.02$1.02$1.74$2.39——
Capital allocation
Dividends paid————————$0—
Share buybacks (net)———$0$0$0$0$55,138$0$0
Capex / revenue161.7%—————————
Capex / depreciation1.491.920.680.750.270.231.122.822.290.56
Stock-based compensation / revenue13,885.1%—————————
R&D / revenue94,152.6%—————————
SG&A / revenue17,660.4%—————————
Efficiency
Days of inventory on hand—-24,228.8—-434.7-294.2-179.9-204.6———
Days payables outstanding17,237.020,283.69,847.43,577.21,037.9170.5141.4156.9703.21,482.0
Receivables turnover—0.000.000.000.000.000.00———
Payables turnover0.020.020.040.100.352.142.582.330.520.25
Asset turnover0.000.000.000.000.000.000.000.000.000.00
Average receivables—$1.2M$504,774$251,214$244,382$190,000$190,000———
Average payables$7.9M$7.2M$3.9M$2.1M$862,238$180,075$131,292$95,862$201,724$296,644
Average inventory—−$8.6M—−$251,214−$244,382−$190,000−$190,000—$0—
Intangibles / total assets0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Computed from CELC's annual financial statements (latest annual report filed March 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

CELC valuation and financial ratios

Celcuity earned a return on equity of −163.8% in fiscal 2025. It ended the year with $195.4 million of debt and $441.5 million in cash and short-term investments, a net cash position of $246.1 million.

See the CELC income statement, the CELC chart for price history, or the CELC stock overview for the latest quote and news.

CELC key metrics FAQ

What is Celcuity's return on equity?

Celcuity's return on equity (ROE) was −163.8% in fiscal 2025: net income of -$177.0 million on average shareholders' equity of $108.1 million.

How much debt does Celcuity have?

Celcuity had total debt of $195.4 million at the end of fiscal 2025, a debt-to-equity ratio of 1.94 and more cash than debt.

What is Celcuity's free cash flow yield?

Celcuity generated -$153.5 million of free cash flow in fiscal 2025, a free cash flow yield of −2.9% on its market value at year-end ($5.2 billion).

What is Celcuity's current ratio?

Celcuity's current ratio was 10.55 at the end of fiscal 2025: current assets were 10.55 times current liabilities.

Biotechnology key metrics